CN101804105B - Medicine composition for treating mammitis and preparation method thereof - Google Patents
Medicine composition for treating mammitis and preparation method thereof Download PDFInfo
- Publication number
- CN101804105B CN101804105B CN201010146994XA CN201010146994A CN101804105B CN 101804105 B CN101804105 B CN 101804105B CN 201010146994X A CN201010146994X A CN 201010146994XA CN 201010146994 A CN201010146994 A CN 201010146994A CN 101804105 B CN101804105 B CN 101804105B
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- radix
- fructus
- mastitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicine composition for treating mammitis. The medicine composition is a medicine which is prepared with the following medicinal materials in part by weight: 1 to 10 parts of Chinese thorowax root, 1 to 10 parts of baical skullcap root, 1 to 10 parts of white paeony root, 1 to 5 parts of red-rooted salvia root, 1 to 10 parts of mongolian dandelion herb, 1 to 5 parts of Chinese angelica, 1 to 10 parts of frankincense, 1 to 10 parts of fructus forsythiae, 1 to 5 parts of great burdock achene and 1 to 10 parts of beautiful sweetgum fruit. The invention also relates to a preparation method for the medicine composition. The beautiful sweetgum fruit has the advantages of reasonable formula and remarkable curative effect, and can be used for effectively treating mammitis.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition for the treatment of mastitis and preparation method thereof.
Background technology
Mastitis are meant that the acute festering type of mammary gland infects, and are the puerperal commonly encountered diseases, are one of reasons that causes puerperal fever, are most commonly in the nursing women, especially the primipara.Any time of age of sucking all can take place, and the beginning of suckling is the most common.
Mastitis generally cause owing to underlying cause:
1. the alluvial of milk: human milk silt helps invading the growth and breeding of antibacterial.Reason has: 1. hypomastia or cave in, hinder suckling, and the anemia of pregnant woman is antenatal to fail in time to correct retracted nipple, the difficulty when baby inhales breast; 2. hypergalactosis, emptying is incomplete, and the puerpera is not in time with unnecessary milk emptying in the breast.3. latex dust is obstructed, the latex dust inflammation, and tumor and external compressing, the fiber that medicated bra comes off also can stop up latex dust.
2. the baby inhales the breast difficulty during intrusion retracted nipple of antibacterial, easily causes peripapillary breakage, is antibacterial is caused infection along the lymphatic vessel invasion main path.The baby often contains nipple and sleeps in addition, inflammation is directly invaded spread to latex dust, diffuses to then that matter causes pyogenic infection between mammary gland.Its pathogenic bacterium are common with staphylococcus aureus.
The clinical manifestation of mastitis is:
1. the distending pain that the acute simple mastitis initial stage mainly is a breast, ill-defined scleroma appears in local Pi Wengao, tenderness, and tenderness is arranged.
2. acute festering type mastitis local skin is red, swollen, hot, bitterly, more significantly scleroma occurs, touches a tender spot more, and shiver with cold, hyperpyrexia, headache, unable, the empty shape of whole body such as arteries and veins is fast can appear in patient simultaneously.This moment, the lymph node of enlargement can appear in the oxter, and tenderness is arranged, and the blood test numeration of leukocyte raises, and can merge septicemia when serious.
3. abscess forms because the treatment measure is incapable or the state of an illness further increases the weight of, and the mutual fusion of the focus of infection that local organization necroses, liquefies, differs in size forms abscess.Abscess can be single room or many rooms property.The abscess of shallow table easily is found, and darker abscess fluctuation is not obvious, is difficult for finding.If mastitis patient General Symptoms is obvious, when part and systemic drug therapeutic effect are not obvious, note carrying out the puncture of painful area, wait to extract out the diagnosis of finding the clear and definite abscess of leukocyte in pus or the smear.
Mastitis can be diagnosed and differentiate by following means:
Acute mastitis mostly occurred in primipara age of sucking, and onset is anxious, occurred in the early stage breast that a limitation is red, swollen, hot, the pain lump, accompanied fear of cold, whole body such as heating poisoning symptom.Fail in time to control when acute inflammation, develop the formation abscess after a couple of days rapidly, local puncture is extracted into pus and can makes a definite diagnosis.Acute mastitis should be noted differentiating with the inflammatory breast carcinoma:
1. acute mastitis is from the beginning of mostly occurring at a certain section of mammary gland, and the inflammatory breast cancer cell extensively soaks into the netted lymphatic vessel of skin, so pathological changes is involved most of breast, and skin is orange peel appearance;
2. can touch huge lump in the inflammatory breast cancer breast, the red swelling of the skin scope is very wide, but local tenderness and whole body poisoning symptom are all lighter, and the puncture cytolgical examination can find cancerous cell to determine diagnosis.
Present treatment for mastitis also is emphasis and the focus during women and children work.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of mastitis.
The present invention also aims to provide the preparation of drug combination method of these treatment mastitis.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of mastitis, it is characterized in that it is the medicament of being made by weight by following bulk drugs:
1～5 part of 1～10 part of Radix Salviae Miltiorrhizae of 1～10 portion of Radix Paeoniae Alba of 1～10 part of Radix Scutellariae of Radix Bupleuri
1～10 part of 1～10 part of Fructus Forsythiae of 1～5 part of Olibanum of 1～10 part of Radix Angelicae Sinensis of Herba Taraxaci
1～10 part of 1～5 part of Fructus Liquidambaris of Fructus Arctii.
Preferably, the medicament made by weight by following bulk drugs of Chinese medicine composition of the present invention:
3 parts of 6 parts of Radix Salviae Miltiorrhizaes of 5 portions of Radix Paeoniae Albas of 5 parts of Radix Scutellariaes of Radix Bupleuri
10 parts of 5 parts of Fructus Forsythiaes of 2 parts of Olibanums of 10 parts of Radix Angelicae Sinensis of Herba Taraxaci
5 parts of 5 parts of Fructus Liquidambaris of Fructus Arctii.
Pharmaceutical composition of the present invention can be made various dosage forms with pharmaceutically acceptable carrier, such as tablet, capsule, soft capsule, pill, granule, drop pill or decoction etc.Can adopt preparation technique means well known in the art to finish preparation of drug combination of the present invention.
Described pharmaceutically acceptable carrier is well known, for being used to prepare the usual excipients or the adjuvant of above-mentioned preparation.Excipient or adjuvant commonly used comprise (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant or the like, for example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate or the like.
The present invention also provides a kind of preparation of drug combination method for the treatment of mastitis, this method comprises: get Radix Bupleuri 50 grams, Radix Scutellariae 50 grams, the Radix Paeoniae Alba 60 grams, Radix Salviae Miltiorrhizae 30 grams, Herba Taraxaci 100 grams, Radix Angelicae Sinensis 20 grams, Olibanum 50 grams, Fructus Forsythiae 100 grams, Fructus Arctii 50 grams, Fructus Liquidambaris 50 grams, the water (weight that is meant water herein is 10 times of all medical material gross weights) that adds 10 times of medical material weight, heated 2 hours down at 80 ℃, filter, filtrate is concentrated into 300 milliliters, promptly
The reasonable recipe of pharmaceutical composition of the present invention, curative effect is clear and definite, can treat mastitis effectively.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Radix Bupleuri 50 grams, Radix Scutellariae 50 grams, the Radix Paeoniae Alba 60 grams, Radix Salviae Miltiorrhizae 30 grams, Herba Taraxaci 100 grams, Radix Angelicae Sinensis 20 grams, Olibanum 50 grams, Fructus Forsythiae 100 grams, Fructus Arctii 50 grams, Fructus Liquidambaris 50 grams, the water that adds 10 times of medical material weight heated 2 hours down at 80 ℃, filtered, filtrate is concentrated into 300 milliliters, promptly.
Experimental example
Physical data:
20 routine patients all are in age of sucking.Product reckling in age 22 years old, the maximum 35 years old; All went to a doctor in 1～7 day in morbidity.Clinical manifestation: mammary swelling, pain, the unclear lump in boundary line appears, tangible tenderness is arranged, surface skin is little red or red and swollen, with General Symptomies such as heating (body temperature is at 38 ℃～39 ℃), aversion to cold, headache, whole body discomforts.
Therapeutic Method:
Use the decoction of preparation among the embodiment 1, take each 30 milliliters every day 2 times.One week was 1 course of treatment.
Curative effect determinate standard:
General Symptoms disappears, and lump all is dissipated as healing.
Therapeutic outcome:
After a course of treatment, whole 20 routine patients all cure.
Claims (3)
1. a pharmaceutical composition for the treatment of mastitis is characterized in that, it is the medicament of being made by weight by following bulk drugs:
1～5 part of 1～10 part of Radix Salviae Miltiorrhizae of 1～10 portion of Radix Paeoniae Alba of 1～10 part of Radix Scutellariae of Radix Bupleuri
1～10 part of 1～10 part of Fructus Forsythiae of 1～5 part of Olibanum of 1～10 part of Radix Angelicae Sinensis of Herba Taraxaci
1～10 part of 1～5 part of Fructus Liquidambaris of Fructus Arctii.
2. the pharmaceutical composition of treatment mastitis according to claim 1 is characterized in that, it is the medicament of being made by weight by following bulk drugs:
3 parts of 6 parts of Radix Salviae Miltiorrhizaes of 5 portions of Radix Paeoniae Albas of 5 parts of Radix Scutellariaes of Radix Bupleuri
10 parts of 5 parts of Fructus Forsythiaes of 2 parts of Olibanums of 10 parts of Radix Angelicae Sinensis of Herba Taraxaci
5 parts of 5 parts of Fructus Liquidambaris of Fructus Arctii.
3. preparation of drug combination method for the treatment of mastitis, this method comprises:
Get Radix Bupleuri 50 grams, Radix Scutellariae 50 grams, the Radix Paeoniae Alba 60 grams, Radix Salviae Miltiorrhizae 30 grams, Herba Taraxaci 100 grams, Radix Angelicae Sinensis 20 grams, Olibanum 50 grams, Fructus Forsythiae 100 grams, Fructus Arctii 50 grams, Fructus Liquidambaris 50 grams, the water that adds 10 times of medical material weight heated 2 hours down at 80 ℃, filtered, filtrate is concentrated into 300 milliliters, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010146994XA CN101804105B (en) | 2010-04-15 | 2010-04-15 | Medicine composition for treating mammitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010146994XA CN101804105B (en) | 2010-04-15 | 2010-04-15 | Medicine composition for treating mammitis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101804105A CN101804105A (en) | 2010-08-18 |
| CN101804105B true CN101804105B (en) | 2011-11-16 |
Family
ID=42606165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010146994XA Expired - Fee Related CN101804105B (en) | 2010-04-15 | 2010-04-15 | Medicine composition for treating mammitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101804105B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104587091A (en) * | 2015-02-04 | 2015-05-06 | 刘小芳 | Medicament for treating mammitis |
| CN105381307A (en) * | 2015-12-18 | 2016-03-09 | 青岛友诚高新技术有限公司 | Traditional Chinese medicine composition for treating mastitis and preparing method thereof |
| CN106176955A (en) * | 2016-07-22 | 2016-12-07 | 太仓市爱农奶牛专业合作社 | A kind of antiinflammatory treating mammitis of cow and preparation method thereof |
| CN106038837A (en) * | 2016-08-02 | 2016-10-26 | 韦爱小 | Traditional Chinese medicine composition for treating acute mastitis |
| CN108607004A (en) * | 2018-06-21 | 2018-10-02 | 浙江美丽禾生物科技有限公司 | A kind of Chinese medicine preparation and preparation method for treating puerperal mastitis |
| CN114053327A (en) * | 2021-12-14 | 2022-02-18 | 重庆秀佰颜软件开发有限公司 | Pure traditional Chinese medicine preparation for effectively conditioning and preventing female mastitis and preparation process |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101099826A (en) * | 2006-07-06 | 2008-01-09 | 杨文龙 | Traditional Chinese medicine tablet for treating mastopathy and its preparation process |
-
2010
- 2010-04-15 CN CN201010146994XA patent/CN101804105B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101099826A (en) * | 2006-07-06 | 2008-01-09 | 杨文龙 | Traditional Chinese medicine tablet for treating mastopathy and its preparation process |
Non-Patent Citations (2)
| Title |
|---|
| 王霞.急性乳腺炎中医中西医结合治疗进展.《国医论坛》.2005,第20卷(第2期),54－56. * |
| 郑中杰.中药治疗急性乳腺炎48例.《中国民间疗法》.2005,第13卷(第5期),23-24. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101804105A (en) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804105B (en) | Medicine composition for treating mammitis and preparation method thereof | |
| CN102552432A (en) | External Chinese medicinal herb for treating mastitis | |
| CN103349766B (en) | Pharmaceutical composition for endless postpartum lochia | |
| CN103083476B (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN101112486B (en) | Chinese traditional medicine composition for treating mammitis | |
| CN104906465A (en) | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof | |
| CN102895466A (en) | Chinese medicine for preventing miscarriages and preparation method for Chinese medicine | |
| CN103386102B (en) | Pharmaceutical composition for curing postpartum bleeding and preparation method thereof | |
| CN101829315A (en) | Traditional Chinese medicine composition for treating headache during menstruation and preparation method thereof | |
| CN102657744B (en) | Medicament for treating mastitis | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN102526620A (en) | Traditional Chinese medicinal composition for treating gynecological inflammation and application of same | |
| CN102319317A (en) | Traditional Chinese medicine composition for treating menstrual disorder and preparation method thereof | |
| CN103223046A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN103041363B (en) | Medicament for treating mammitis | |
| CN103381210B (en) | Traditional Chinese medicine preparation for treating plasma cell mastitis, and preparation method thereof | |
| CN105232971A (en) | Traditional Chinese medicine composition for treating metrorrhagia and metrostaxis with kidney yin deficiency symptom | |
| CN105148020A (en) | Traditional Chinese medicine composition for treating qi-failing-to-control-blood type metrorrhagia and metrostaxis | |
| CN106668240A (en) | Pharmaceutical composition for treating vitreous opacity | |
| CN103536810B (en) | Medicament for treating breast hyperplasia | |
| CN106309636B (en) | Pharmaceutical composition for uterine bleeding | |
| CN104398913A (en) | Medicament for treating dysmenorrheal and preparation method thereof | |
| CN102488865B (en) | Traditional Chinese medicine for fast healing of postoperative incision | |
| CN104740528B (en) | A kind of traditional Chinese medicine powder for treating cervicitis | |
| CN106421596A (en) | Pharmaceutical composition for treating mastitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111116 Termination date: 20120415 |